Metropolitan Life Insurance Company (MetLife)’s Agilent Technologies A Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,819
| Closed | -$1.72M | – | 11 |
|
|
2024
Q1 | $1.72M | Sell |
11,819
-90
| -0.8% | -$12.3K | 0.07% | 225 |
|
|
2023
Q4 | $1.66M | Sell |
11,909
-311
| -3% | -$37K | 0.08% | 214 |
|
|
2023
Q3 | $1.37M | Sell |
12,220
-666
| -5% | -$79.8K | 0.07% | 245 |
|
|
2023
Q2 | $1.55M | Sell |
12,886
-346
| -3% | -$44.1K | 0.08% | 234 |
|
|
2023
Q1 | $1.83M | Sell |
13,232
-3,473
| -21% | -$508K | 0.09% | 195 |
|
|
2022
Q4 | $2.5M | Sell |
16,705
-700
| -4% | -$99.9K | 0.11% | 178 |
|
|
2022
Q3 | $2.12M | Sell |
17,405
-292
| -2% | -$37.5K | 0.1% | 195 |
|
|
2022
Q2 | $2.1M | Sell |
17,697
-461
| -3% | -$56.7K | 0.09% | 210 |
|
|
2022
Q1 | $2.4M | Sell |
18,158
-28,801
| -61% | -$3.96M | 0.09% | 220 |
|
|
2021
Q4 | $7.5M | Sell |
46,959
-1,133
| -2% | -$176K | 0.1% | 158 |
|
|
2021
Q3 | $7.58M | Sell |
48,092
-1,596
| -3% | -$258K | 0.11% | 146 |
|
|
2021
Q2 | $7.34M | Buy |
49,688
+11,213
| +29% | +$1.53M | 0.1% | 151 |
|
|
2021
Q1 | $4.89M | Sell |
38,475
-2,193
| -5% | -$271K | 0.07% | 215 |
|
|
2020
Q4 | $4.82M | Sell |
40,668
-2,428
| -6% | -$269K | 0.07% | 208 |
|
|
2020
Q3 | $4.35M | Sell |
43,096
-1,959
| -4% | -$189K | 0.07% | 211 |
|
|
2020
Q2 | $3.98M | Sell |
45,055
-2,641
| -6% | -$216K | 0.07% | 220 |
|
|
2020
Q1 | $3.42M | Sell |
47,696
-244
| -0.5% | -$19.6K | 0.07% | 229 |
|
|
2019
Q4 | $4.09M | Buy |
47,940
+31
| +0.1% | +$2.44K | 0.07% | 256 |
|
|
2019
Q3 | $3.67M | Buy |
47,909
+593
| +1% | +$42.8K | 0.06% | 261 |
|
|
2019
Q2 | $3.53M | Buy |
47,316
+3,197
| +7% | +$237K | 0.06% | 281 |
|
|
2019
Q1 | $3.55M | Sell |
44,119
-1,725
| -4% | -$131K | 0.06% | 253 |
|
|
2018
Q4 | $3.09M | Buy |
45,844
+180
| +0.4% | +$12.1K | 0.06% | 256 |
|
|
2018
Q3 | $3.22M | Sell |
45,664
-1,900
| -4% | -$126K | 0.05% | 289 |
|
|
2018
Q2 | $2.94M | Sell |
47,564
-5,398
| -10% | -$352K | 0.05% | 330 |
|
|
2018
Q1 | $3.54M | Buy |
52,962
+406
| +0.8% | +$28.5K | 0.05% | 273 |
|
|
2017
Q4 | $3.52M | Sell |
52,556
-102,976
| -66% | -$6.95M | 0.05% | 282 |
|
|
2017
Q3 | $9.98M | Sell |
155,532
-3,083
| -2% | -$192K | 0.06% | 274 |
|
|
2017
Q2 | $9.41M | Sell |
158,615
-4,095
| -3% | -$233K | 0.07% | 271 |
|
|
2017
Q1 | $8.6M | Sell |
162,710
-3,508
| -2% | -$177K | 0.06% | 313 |
|
|
2016
Q4 | $7.57M | Sell |
166,218
-5,297
| -3% | -$240K | 0.05% | 340 |
|
|
2016
Q3 | $8.08M | Sell |
171,515
-2,568
| -1% | -$120K | 0.06% | 304 |
|
|
2016
Q2 | $7.72M | Buy |
174,083
+1,944
| +1% | +$83.8K | 0.06% | 319 |
|
|
2016
Q1 | $6.86M | Sell |
172,139
-5,060
| -3% | -$193K | 0.05% | 358 |
|
|
2015
Q4 | $7.41M | Sell |
177,199
-4,257
| -2% | -$165K | 0.06% | 321 |
|
|
2015
Q3 | $6.23M | Sell |
181,456
-4,236
| -2% | -$160K | 0.04% | 397 |
|
|
2015
Q2 | $7.16M | Sell |
185,692
-4,857
| -3% | -$202K | 0.05% | 371 |
|
|
2015
Q1 | $7.92M | Sell |
190,549
-1,212
| -0.6% | -$49K | 0.06% | 334 |
|
|
2014
Q4 | $7.85M | Sell |
191,761
-73,533
| -28% | -$2.97M | 0.05% | 341 |
|
|
2014
Q3 | $10.8M | Sell |
265,294
-3,778
| -1% | -$154K | 0.08% | 249 |
|
|
2014
Q2 | $11.1M | Sell |
269,072
-13,328
| -5% | -$535K | 0.08% | 258 |
|
|
2014
Q1 | $11.3M | Sell |
282,400
-2,364
| -0.8% | -$97.3K | 0.08% | 251 |
|
|
2013
Q4 | $11.6M | Sell |
284,764
-3,554
| -1% | -$135K | 0.08% | 242 |
|
|
2013
Q3 | $10.6M | Sell |
288,318
-12,961
| -4% | -$437K | 0.08% | 249 |
|
|
2013
Q2 | $9.21M | Buy |
+301,279
| New | +$9.36M | 0.07% | 276 |
|
Other funds holding A
Metropolitan Life Insurance Company (MetLife)'s A Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Agilent Technologies (A) in Q2 2024, closing a stake of 11,819 shares — an estimated $1.72M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in A in Q2 2013 and held it in 44 quarters. The position peaked at $11.6M in Q4 2013. 1,011 funds tracked by Wall St. Rank hold A as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Agilent Technologies position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 11,819 Agilent Technologies shares in Q2 2024, an estimated $1.72M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Agilent Technologies in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Agilent Technologies position peaked at $11.6M in Q4 2013.
- 1,011 funds tracked by Wall St. Rank held Agilent Technologies as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.